Using the Apple Ecosystem to Support Health Research and Clinical Trials

In a recent note, I discussed how23andMe was beginning to recruit clinical trial subjects as a new business opportunity (see:23andMe Moving into Clinical Trial Recruitment, a Potential Source of New Income). I emphasized in the note that this was a lucrative new enterprise because drug companies offer high reimbursement for recruiting research subjects. Subsequent to posting this note, I came across another article that speculates that Apple has been eyeing the medical research market with the potential to radically change some aspects of it (see:Apple Is Going After The Healthcare Industry, Starting With Personal Health Data). Here is an excerpt from this article:By having a relationship directly with consumers via the iPhone, Apple is able to reduce the friction of signing up for a study, as well as identify eligible candidates using their health record. Moreover, participants inResearchKit [andCareKit] studies are not geographically constrained and can come from around the world.But while simplifying the sign-up process and increasing accessibility theoretically means a broader population demographic to take part in trials, it ’s still limited to the demographic of iPhone users, who tend to be more affluent.By simplifying recruitment, the size of the studies on ResearchKit are much larger than traditional studies. TheApple Heart Study has recruited more than 400,000 people in a year.A mobile Parkinson ’s study known asmPower has more than 10,000 enrollees. For re...
Source: Lab Soft News - Category: Laboratory Medicine Authors: Tags: Clinical Lab Industry News Clinical Lab Testing Electronic Health Record (EHR) Genomic Testing Health Wearable Healthcare Information Technology Lab Industry Trends Medical Research Point-of-Care Testing Test Kits and Home Testing Source Type: blogs